SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-011510
Filing Date
2022-11-17
Accepted
2022-11-17 17:09:29
Documents
1
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 form4-11172022_101117.html 4  
1 form4-11172022_101117.xml 4 20456
  Complete submission text file 0001415889-22-011510.txt   22050
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Torley Helen (Reporting) CIK: 0001528185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 221399334